Table 1.
Study | National Clinical Trial Identifier |
---|---|
NSCLC | |
EA4512 (ALCHEMIST) | NCT02201992 |
A081105 (ALCHEMIST) | NCT02193282 |
EA5142 (ANVIL) | NCT02595944 |
RTOG 1308 | NCT01993810 |
RTOG 1106 | NCT01507428 |
RTOG 1306 | NCT01822496 |
S1400 (Lung-MAP) | NCT02154490 |
S1403 | NCT02438722 |
CALGB 140503 | NCT00499330 |
AFT-09 | NCT02591615 |
ACCRU RC1126 | NCT01532089 |
CTONG 1103 (EMERGING) | NCT01407822 |
CTONG 1104 (ADJUVANT) | NCT01405079 |
EORTC 22055-08053 (LUNG ART) | NCT00410683 |
EORTC 08114 (GEM) | NCT01838577 |
BR31 | NCT02273375 |
IND219 | NCT02337530 |
SCLC | |
CALGB 30610/RTOG 0538 | NCT00632853 |
ETOP 4-13 (STIMULI) | NCT02046733 |
Mesothelioma | |
CALGB 30901 | NCT01085630 |
Abbreviations: NSCLC = non–small-cell lung cancer; SCLC = small-cell lung cancer.